General Information
BounceWatch is an independent company data service, not affiliated with AQUILAB by Coexya. To contact AQUILAB by Coexya, visit aquilab.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does AQUILAB by Coexya compare?
A PDF of AQUILAB by Coexya and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting AQUILAB by Coexya soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is AQUILAB by Coexya on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
France Market
Health Care
About AQUILAB by Coexya
Business keywords: Medical Imaging Solutions, Radiotherapy Software, Quality Assurance Software, Oncology Solutions, Clinical Trial Facilitation, Multimodality Imaging, Software Development, Hospital Engineering, ICT Solutions, Innovative Healthcare Technologies, Machine QA Software, Data Exchange Platform, Research and Innovation
Services & Products
Target Customers
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Non Equity Assistance | Undisclosed | 1 |
Eurasante
|
01 Feb 2001 |
AQUILAB by Coexya Alternatives & Competitors
View All AlternativesProsoma Digital Healthcare provides comprehensive solutions that improve the quality of life for can...
Conquer cancer by re-envisioning radiation therapy.
FAQ About AQUILAB by Coexya
Source: BounceWatch company record for AQUILAB by Coexya, https://bouncewatch.com/company/aquilab, updated 11 June 2025. When citing, please name BounceWatch and link this page.